Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pupil dilation indexes - but does not causally influence - conscious error detection: a double-blind, placebo-controlled investigation of performance-monitoring using atomoxetine.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026

Same author

Emergency Department Boarding for Older Adults: The Impact of Geography, Temporal Trends, and Dementia Status.

Annals of emergency medicine·2026

Same author

Guideline-concordance along the cancer care continuum and breast cancer mortality by race and ethnicity: a SEER-Medicare study.

Cancer causes & control : CCC·2026

Same author

Dual-target theta burst rTMS for the treatment of methamphetamine use disorder: An open-label pilot clinical trial.

Brain stimulation·2025

Same author

Changes in first-line treatment patterns according to frailty in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Leukemia & lymphoma·2025

Same author

Relationship of the revised anticholinergic drug scale with cultured cell-based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depression.

Pharmacotherapy·2025

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Acamprosate.

William Klugh Kennedy¹, Megan Leloux, Eric C Kutscher

¹Mercer University College of Pharmacy and School of Medicine-Savannah Campus, Memorial University Medical Center, 4700 Waters Avenue, Savannah, GA 31403, USA. Kennedy_wk@mercer.edu

Expert Opinion on Drug Metabolism & Toxicology

|February 19, 2010

Summary

This summary is machine-generated.

Acamprosate is a safe and effective medication for maintaining alcohol abstinence. It is often used alongside non-drug therapies, showing significant effectiveness in clinical trials for alcohol dependence treatment.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

Related Experiment Videos

Last Updated: Jun 16, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

Area of Science:

Neuroscience
Pharmacology
Addiction Medicine

Background:

Alcohol dependence is a significant cause of illness and death with high societal costs.
Treatment of alcohol dependence is challenging, with high rates of relapse.
Acamprosate offers an effective treatment option for alcohol dependence with a unique mechanism of action.

Purpose of the Study:

To review the current literature on acamprosate for alcohol dependence treatment.
To evaluate the efficacy and effectiveness of acamprosate based on clinical trials and meta-analyses.
To provide an understanding of acamprosate's mechanism of action, safety, and tolerability.

Main Methods:

Systematic review of published literature on acamprosate.
Focused on comparative clinical trials and meta-analyses.
Searched PubMed using the MeSH term 'acamprosate', excluding animal and non-English studies.

Main Results:

Acamprosate is safe and effective for maintaining alcohol abstinence.
Effect sizes in reviewed studies ranged from 1.3 to 2.
The review provides a synopsis of recent literature on acamprosate's effectiveness.

Conclusions:

Acamprosate is a valuable tool in managing alcohol dependence.
It is most effective when used in conjunction with non-pharmacologic therapies.
The drug demonstrates a significant effect size in promoting abstinence.